| 臺大學術典藏 |
2020-03-07T06:48:16Z |
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
|
Ayhan A.;Tsui-Lien Mao;Suryo Rahmanto Y.;Zeppernick F.;Ogawa H.;Wu R.-C.;Wang T.-L.;Shih I.-M.; Ayhan A.; TSUI-LIEN MAO; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-07T06:48:16Z |
The roles of ARID1A in gynecologic cancer
|
TSUI-LIEN MAO; Shih I.-M. |
| 臺大學術典藏 |
2020-03-07T06:42:19Z |
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma
|
KUAN-TING KUO; Mao T.-L.; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-07T06:42:19Z |
Power of the eternal youth: Nanog expression in the gestational choriocarcinoma
|
Shih I.-M.; KUAN-TING KUO |
| 臺大學術典藏 |
2020-03-07T06:42:18Z |
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42))
|
KUAN-TING KUO; Guan B.; Feng Y.; Mao T.-L.; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-07T06:42:18Z |
Analysis of DNA copy number alterations in Ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas
|
Wang T.-L.; Shih I.-M.; KUAN-TING KUO; Guan B.; Feng Y.; Mao T.-L.; Chen X.; Jinawath N.; Wang Y.; Kurman R.J. |
| 臺大學術典藏 |
2020-03-07T06:42:16Z |
Somatic mutations of PPP2R1A in ovarian and uterine carcinomas
|
Shih I.-M. ;Panuganti P.K. ;Kuan-Ting Kuo ;Mao T.-L. ;Kuhn E. ;Jones S. ;Velculescu V.E. ;Kurman R.J. ;Wang T.-L.; Shih I.-M.; Panuganti P.K.; KUAN-TING KUO; Mao T.-L.; Kuhn E.; Jones S.; Velculescu V.E.; Kurman R.J.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-07T06:42:16Z |
DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma
|
Wang T.-L.; Kurman R.J.; Shih I.-M.; Glas R.; Ma M.J.; Nakayama K.; Wang Y.; Kuan-Ting Kuo;Mao T.-L.;Chen X.;Feng Y.;Nakayama K.;Wang Y.;Glas R.;Ma M.J.;Kurman R.J.;Shih I.-M.;Wang T.-L.; KUAN-TING KUO; Mao T.-L.; Chen X.; Feng Y. |
| 臺大學術典藏 |
2020-03-07T06:42:13Z |
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses
|
Yuan X.; Wei L.; Roden R.B.S.; KUAN-TING KUO; Nakayama K.; Clarke B.; Shaw P.; Olvera N.; Kurman R.J.; Levine D.A.; Wang T.-L.; Shih I.-M.; Kuhn E.; Wu R.-C.; Guan B.; Wu G.; Zhang J.; Wang Y.; Song L. |
| 臺大學術典藏 |
2020-03-07T06:42:12Z |
Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma
|
Mao T.-L.; Ardighieri L.; Ayhan A.; KUAN-TING KUO; Wu C.-H.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-06T08:25:27Z |
HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions
|
Mao T.-L.;Kurman R.J.;Yung-Ming Jeng;Huang W.;Shih I.-M.; Mao T.-L.; Kurman R.J.; YUNG-MING JENG; Huang W.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-06T08:25:18Z |
Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma
|
Guan B. ;Mao T.-L. ;Panuganti P.K. ;Kuhn E. ;Kurman R.J. ;Maeda D. ;Chen E. ;Yung-Ming Jeng ;Wang T.-L. ;Shih I.-M.; Guan B.; Mao T.-L.; Panuganti P.K.; Kuhn E.; Kurman R.J.; Maeda D.; Chen E.; YUNG-MING JENG; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:56Z |
Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor - An aid in differential diagnosis
|
TSUI-LIEN MAO; Seidman J.D.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:56Z |
Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma
|
TSUI-LIEN MAO; Hsu C.-Y.; Yen M.J.; Gilks B.; Sheu J.J.-C.; Gabrielson E.; Vang R.; Cope L.; Kurman R.J.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:56Z |
Notch3 gene amplification in ovarian cancer
|
Park J.T.; Li M.; Nakayama K.; TSUI-LIEN MAO; Davidson B.; Zhang Z.; Kurman R.J.; Eberhart C.G.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:55Z |
Immunohistochemistry of choriocarcinoma: An aid in differential diagnosis and in elucidating pathogenesis
|
TSUI-LIEN MAO; Kurman R.J.; Huang C.-C.; Lin M.-C.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:55Z |
HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions
|
Huang W.; Shih I.-M.; TSUI-LIEN MAO; Kurman R.J.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:55Z |
Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasion
|
Yemelyanova A.; TSUI-LIEN MAO; Nakayama N.; Shih I.M.; Kurman R.J. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
|
K?bel M.; Xu H.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D.; Gilks C.B. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42))
|
Kuo K.-T.; Guan B.; Feng Y.; TSUI-LIEN MAO; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Cystic and adenofibromatous clear cell carcinomas of the ovary: Distinctive tumors that differ in their pathogenesis and behavior: A clinicopathologic analysis of 122 cases
|
Veras E.; TSUI-LIEN MAO; Ayhan A.; Ueda S.; Lai H.; Hayran M.; Shih I.-M.; Kurman R.J. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Analysis of DNA copy number alterations in Ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas
|
Kuo K.-T.; Guan B.; Feng Y.; TSUI-LIEN MAO; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93
|
Ueda S.M.; TSUI-LIEN MAO; Kuhajda F.P.; Vasoontara C.; Giuntoli R.L.; Bristow R.E.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma
|
Kuo K.-T.; TSUI-LIEN MAO; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma
|
Jones S.; Wang T.-L.; Shih I.-M.; TSUI-LIEN MAO; Nakayama K.; Roden R.; Glas R.; Slamon D.; Diaz Jr. L.A.; Vogelstein B.; Kinzler K.W.; Velculescu V.E.; Papadopoulos N. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma
|
Maeda D.; TSUI-LIEN MAO; Fukayama M.; Nakagawa S.; Yano T.; Taketani Y.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma
|
Kuo K.-T.; TSUI-LIEN MAO; Chen X.; Feng Y.; Nakayama K.; Wang Y.; Glas R.; Ma M.J.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Lack of a Y-chromosomal complement in the majority of gestational trophoblastic neoplasms
|
Yap K.L.; Hafez M.J.; TSUI-LIEN MAO; Kurman R.J.; Murphy K.M.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:53Z |
Advances in the diagnosis of gestational trophoblastic tumors and tumor-like lesions
|
TSUI-LIEN MAO; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Somatic mutations of PPP2R1A in ovarian and uterine carcinomas
|
Shih I.-M.; Panuganti P.K.; Kuo K.-T.; TSUI-LIEN MAO; Kuhn E.; Jones S.; Velculescu V.E.; Kurman R.J.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A
|
Wu C.H.; TSUI-LIEN MAO; Vang R.; Ayhan A.; Wang T.-L.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:52Z |
Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma
|
Guan B.; TSUI-LIEN MAO; Panuganti P.K.; Kuhn E.; Kurman R.J.; Maeda D.; Chen E.; Jeng Y.-M.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma
|
Ayhan A.; TSUI-LIEN MAO; Seckin T.; Wu C.-H.; Guan B.; Ogawa H.; Futagami M.; Mizukami H.; Yokoyama Y.; Kurman R.J.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:50Z |
The roles of ARID1A in gynecologic cancer
|
TSUI-LIEN MAO; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:50Z |
Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma
|
TSUI-LIEN MAO; Ardighieri L.; Ayhan A.; Kuo K.-T.; Wu C.-H.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T12:32:48Z |
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
|
Ayhan A.; Kuhn E.; Wu R.-C.; Ogawa H.; Bahadirli-Talbott A.; TSUI-LIEN MAO; Sugimura H.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T07:52:42Z |
Power of the eternal youth: Nanog expression in the gestational choriocarcinoma
|
Shih I.-M.; KUAN-TING KUO |
| 臺大學術典藏 |
2020-03-05T07:52:40Z |
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42))
|
KUAN-TING KUO; Guan B.; Feng Y.; Mao T.-L.; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T07:52:39Z |
DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma
|
KUAN-TING KUO; Mao T.-L.; Chen X.; Feng Y.; Nakayama K.; Wang Y.; Glas R.; Ma M.J.; Kurman R.J.; Shih I.-M.; Wang T.-L. |
| 臺大學術典藏 |
2020-03-05T07:52:38Z |
Somatic mutations of PPP2R1A in ovarian and uterine carcinomas
|
Wang T.-L.; Kurman R.J.; Velculescu V.E.; Kuhn E.; Jones S.; KUAN-TING KUO; Mao T.-L.; Panuganti P.K.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-05T07:52:37Z |
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses
|
Shih I.-M.; Wang T.-L.; Levine D.A.; Kurman R.J.; Olvera N.; Shaw P.; Clarke B.; Nakayama K.; KUAN-TING KUO; Wei L.; Roden R.B.S.; Yuan X.; Song L.; Kuhn E.; Wu R.-C.; Guan B.; Wu G.; Zhang J.; Wang Y. |
| 臺大學術典藏 |
2020-03-05T07:52:35Z |
Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma
|
Mao T.-L.; Ardighieri L.; Ayhan A.; KUAN-TING KUO; Wu C.-H.; Wang T.-L.; Shih I.-M. |
| 臺大學術典藏 |
2020-03-03T03:06:51Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Wen-Yih Tseng;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; WEN-YIH TSENG; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2020-02-14T02:50:07Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.; Wang T.-L.; Shih I.-M.; Hsieh C.-Y.; Tseng W.-Y.I.; Su Y.-N.; Lee C.-N.; Chen C.-A.; Chai C.-Y.; Hung C.-F.; WEN-FANG CHENG; Wen-Fang Cheng;Hung C.-F.;Chai C.-Y.;Chen C.-A.;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C. |
| 臺大學術典藏 |
2020-02-12T04:06:10Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.;Wang T.-L;Shih I.-M;Hsieh C.-Y;Tseng W.-Y.I;Su Y.-N;CHIEN-NAN LEE;Chen C.-A;Chai C.-Y;Hung C.-F;Cheng W.-F; Cheng W.-F; Hung C.-F; Chai C.-Y; Chen C.-A; CHIEN-NAN LEE; Su Y.-N; Tseng W.-Y.I; Hsieh C.-Y; Shih I.-M; Wang T.-L; Wu T.-C. |
| 臺大學術典藏 |
2020-02-06T05:22:24Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Wu T.-C.;Wang T.-L.;Shih I.-M.;Hsieh C.-Y.;Tseng W.-Y.I.;Su Y.-N.;Lee C.-N.;Chen C.-A.;Chai C.-Y.;Hung C.-F.;WEN-FANG CHENG; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C.; WEN-FANG CHENG; Hung C.-F.; Chai C.-Y.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2020-01-22T07:50:45Z |
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
|
Cheng W.-F.;Hung C.-F.;Chai C.-Y.;Chi-An Chen;Lee C.-N.;Su Y.-N.;Tseng W.-Y.I.;Hsieh C.-Y.;Shih I.-M.;Wang T.-L.;Wu T.-C.; Cheng W.-F.; Hung C.-F.; Chai C.-Y.; CHI-AN CHEN; Lee C.-N.; Su Y.-N.; Tseng W.-Y.I.; Hsieh C.-Y.; Shih I.-M.; Wang T.-L.; Wu T.-C. |
| 臺大學術典藏 |
2017 |
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
|
Wang T.-L.; Shih I.-M.; Sugimura H.; TSUI-LIEN MAO; Bahadirli-Talbott A.; Ogawa H.; Wu R.-C.; Kuhn E.; Ayhan A.; Ayhan A.;Kuhn E.;Wu R.-C.;Ogawa H.;Bahadirli-Talbott A.;Tsui-Lien Mao;Sugimura H.;Shih I.-M.;Wang T.-L. |
| 國立臺灣大學 |
2015 |
INCREASED PROLIFERATION IN AH/EIN WITH CONCURRENT INACTIVATION OF ARID1A AND PTEN TUMOR SUPPRESSORS
|
Ayhan, A.; Mao, T. L.; Rahmanto, Y. Suryo; Zeppernix, F.; Wu, R. C.; Wang, T. L.; Shih, I. M.; 毛翠蓮 |
| 臺大學術典藏 |
2015 |
Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
|
Ayhan A.; TSUI-LIEN MAO; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. |
